Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Forward Pharma A/S logo — Forward Pharma A/S is a Danish biopharmaceutical company

Forward Pharma A/S

Forward Pharma A/S is a Danish biopharmaceutical company

Founded 2005 Denmark Denmark 6 employees Biopharma, Biotechnology +2

General Information

Company Name Forward Pharma A/S
Founded Year 2005
Location Denmark Denmark
Founders / Decision Makers
Team member Team member
Employees 6
Industries Biopharma, Biotechnology, Health Care +1
Social

BounceWatch is an independent company data service, not affiliated with Forward Pharma A/S. To contact Forward Pharma A/S, visit forward-pharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Forward Pharma A/S compare?

A PDF of Forward Pharma A/S and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Forward Pharma A/S soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Forward Pharma A/S

Forward Pharma A/S is a Danish biopharmaceutical company founded in 2005. The company developed a proprietary formulation of DMF for the treatment of inflammatory and neurological indications from 2005 to 2017. Notably, Forward Pharma granted an irrevocable license to all of its IP to Biogen through the License Agreement and received a non-refundable cash fee of $1.25 billion in February 2017. This transaction resulted in the return of EUR 917.7 million to shareholders through a capital reduction in September 2017. In early 2024, Forward Pharma announced the termination of the ADR facility, effective on February 5, 2024. More information about this can be found on the website of the Depositary Bank of New York Mellon (https://www.adrbnymellon.com/files/ad1136444.pdf). The company operates in the biopharma, biotechnology, health care, and pharmaceutical industries. As of now, there is no information available about the last investment or the last investment's investors.

Business keywords: biopharmaceutical company, DMF formulation, inflammatory indications, neurological indications, IP licensing, strategic partnership, profit distribution, immunomodulatory compound, pharmaceutical drug product, immune disorders, multiple sclerosis treatment, psoriasis treatment, international operations, proprietary formulations

No funding data available for Forward Pharma A/S yet.

Forward Pharma A/S Alternatives & Competitors

View All Alternatives
Forward Pharma A/S vs
Realm Therapeutics, Inc.
Realm Therapeutics, Inc. United States

Realm Therapeutics (AIM: RLM) is a clinical-stage biopharmaceutical company focused on developing no...

Post-IPO Equity
2 employees
Biotechnology, Pharmaceutical
Forward Pharma A/S vs
UCB
UCB Belgium

We’re #TeamUCB, a global biopharmaceutical company. 💙 Inspired by patients 🔬 Driven by science

IPO
15278 employees
Biotechnology, Health Care
Forward Pharma A/S vs
Wren Therapeutics
Wren Therapeutics United Kingdom

Stopping the wave of neurodegeneration at its source

Venture round
34 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Forward Pharma A/S

Forward Pharma A/S is a Danish biopharmaceutical company
Forward Pharma A/S was founded in 2005.
Forward Pharma A/S is headquartered in Denmark.
Forward Pharma A/S operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceutical company, DMF formulation, inflammatory indications and neurological indications.
Forward Pharma A/S has approximately 6 employees.
Top alternatives and competitors to Forward Pharma A/S include Realm Therapeutics, Inc., UCB, Wren Therapeutics, Olatec Therapeutics, Mereo BioPharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Forward Pharma A/S and Realm Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Forward Pharma A/S, https://bouncewatch.com/company/forward-pharma-as, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes